8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
VERTEX PHARMACEUTICALS INC / MA (VRTX)

Vertex ($VRTX) issued a press release on Feb 12, 2026 reporting consolidated financial results for the…

Filed with the SEC on · Summarized by InvestorsBot

Vertex ($VRTX) issued a press release on Feb 12, 2026 reporting consolidated financial results for the three and twelve months ended Dec 31, 2025. Press release is attached as Exhibit 99.1 to the Form 8‑K. 📄📅 #VRTX #earnings

$VRTX — Exhibit 99.1 is furnished, not "filed" under Section 18 of the Exchange Act and is not incorporated by reference into registration statements absent specific reference. ⚖️ #SEC #corporate

Investors: review Exhibit 99.1 for full Q4 & FY2025 metrics, commentary and any updated guidance; 8‑K dated Feb 12, 2026. 🔍 $VRTX #earnings #investors

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from VERTEX PHARMACEUTICALS INC / MA

VERTEX ($VRTX) filed Form 8‑K on Feb 12, 2026 (Item 9.01) — exhibits include Press Release (Exhibit 99.1)…

8-K · February 12, 2026